A sobering look at childhood hypertension and its long-term risks
A new editorial in The Lancet highlights a concerning global trend: the prevalence of hypertension in children and adolescents has nearly doubled since 2000, now affecting 4.3% of those aged 3–19 years. This condition, often misperceived as an ailment of adulthood, is the strongest modifiable risk factor for cardiovascular disease and chronic kidney disease. Critically, children diagnosed with hypertension face a two- to threefold higher risk of experiencing major adverse cardiovascular or renal events by early adulthood, underscoring the urgent need for preventative strategies that extend beyond managing childhood obesity.
Why it might matter to you: For hepatologists, this data is directly relevant to the management of pediatric patients with metabolic liver diseases like NAFLD, where hypertension is a common comorbidity. Understanding the amplified cardiovascular risk trajectory from childhood can inform more aggressive monitoring and earlier intervention strategies in at-risk young patients with liver disease. This calls for a more integrated, multidisciplinary approach to pediatric care that considers the liver as part of a broader cardiometabolic system.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
